D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ABCL holding history
AbCellera Biologics Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABCL overviewAll 13F holders of ABCLFull Q2 2026 holdings
- Shares (Q2 2026)
- 45,431
- Value
- $356.6K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 45,431 | $356.6K | <0.1% | +45,431 | New | Holders |
| Q1 2026 | 0 | $0 | 0.0% | −77,776−100.0% | Sold out | Holders |
| Q4 2025 | 77,776 | $266.0K | <0.1% | +1,293+1.7% | Added | Holders |
| Q3 2025 | 76,483 | $384.7K | <0.1% | +25,409+49.7% | Added | Holders |
| Q2 2025 | 51,074 | $175.2K | <0.1% | +51,074 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −420,240−100.0% | Sold out | Holders |
| Q3 2024 | 420,240 | $1.09M | <0.1% | −46,325−9.9% | Reduced | Holders |
| Q2 2024 | 466,565 | $1.38M | <0.1% | +13,330+2.9% | Added | Holders |
| Q1 2024 | 453,235 | $2.05M | <0.1% | +422,602+1,379.6% | Added | Holders |
| Q4 2023 | 30,633 | $174.9K | <0.1% | −404,720−93.0% | Reduced | Holders |
| Q3 2023 | 435,353 | $2.00M | <0.1% | −77,450−15.1% | Reduced | Holders |
| Q2 2023 | 512,803 | $3.31M | <0.1% | −955,593−65.1% | Reduced | Holders |
| Q1 2023 | 1,468,396 | $11.1M | <0.1% | −979,008−40.0% | Reduced | Holders |
| Q4 2022 | 2,447,404 | $24.8M | <0.1% | −327,955−11.8% | Reduced | Holders |
| Q3 2022 | 2,775,359 | $27.4M | <0.1% | +1,672,839+151.7% | Added | Holders |
| Q2 2022 | 1,102,520 | $11.7M | <0.1% | +1,073,423+3,689.1% | Added | Holders |
| Q1 2022 | 29,097 | $284.0K | <0.1% | −37,014−56.0% | Reduced | Holders |
| Q4 2021 | 66,111 | $945.0K | <0.1% | +40,418+157.3% | Added | Holders |
| Q3 2021 | 25,693 | $515.0K | <0.1% | +25,693 | New | Holders |